A case study on obstacles to the growth of biotechnology

  title={A case study on obstacles to the growth of biotechnology},
  author={Nuno Arantes-Oliveira},
  journal={Technological Forecasting and Social Change},

Tables from this paper

Benchmarking biotechnology industries: A comparative perspective
This exploratory paper concerns Spanish biotechnology, a newcomer in the world of molecular biology and its applications. Our central research question is: how different or similar is the national
The Spatial Evolution of the Polish Biotech Industry: A Path-Dependent Process?
Abstract In Poland, similarly to other Central and Eastern European countries, the development of the biotech industry dates back to the late 1980s, when the first private companies were established.
How stakeholder shape innovation in controversial industries: the biotechnology industry in Germany
(OECD 2005, p. 9). Attitudes towards biotechnology are controversial (Cai et al. 2012), especially in Europe: On the one hand, it is seen as future technology (Wydra 2011). With new applications in
Innovation in the biotechnology industry: The role of university-generated intellectual property rights, knowledge base investments and funding mechanisms
The purpose of this paper is to analyze determinants of innovation process effectiveness in the health care biotechnology industry. We use empirical data to highlight specific differences between
Creating a Blue Economy: Research and innovation partnerships to accelerate the development of ocean-related industries
The Blue Economy can be a driver of European growth, through the development of new competences and activities that enable a sustainable exploitation of ocean resources. This paper assesses the
Technology Transfer Suitable Pattern In The Field Of Environmental Biotechnology In Iran
Taking over of appropriate policies in advanced technologies play effective roles in technological progresses in developing countries. Biotechnology as one of the key technologies in twenty-first
Policies to Foster the Creation of Research-Based Spin-offs in Portugal
This paper presents a brief overview of the main government and institutional policies and mechanisms that promote and support (directly or indirectly) the creation of research-based spin-offs, as
Innovation and commercialisation in the Canadian bioproducts industry
Industrial biotechnology is an emerging industry in which firms are developing novel alternatives to petroleum-based goods. Canadian-based firms have an opportunity to capitalise on the availability
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers
The risks faced by biopharmaceutical companies during the process of drug development are multifaceted and complicated. Furthermore, resource intensiveness and the long time perspective force them to


Does New Zealand have an innovation system for biotechnology
Is the Creation and Development of Biotech SMEs Localised? Conclusions Drawn from the French Case
The article examines the localisation effects within biotechnology, concentrating in particular on the French case. The paper has two strands of analysis. The first presents a detailed statistical
How Can We Reap the Fruits of Academic Research in Biotechnology? in Search of Critical Success Factors in Policies for New-Firm Formation
There is often a gap between the creation of knowledge and the use of new knowledge in the economy, a situation which has pushed many governments to establish programmes for knowledge transfer and
Clustering Biotech: A Recipe for Success? Spatial Patterns of Growth of Biotechnology in Munich, Rhineland and Hamburg
The dynamic growth of biotechnology in Germany in recent years has an obviously spatial pattern. Some regions show a substantial potential for start-ups and young firms of this new industry whereas
Signs of life: The growth of biotechnology centers in the U.S
20 The biotechnology industry is built on fundamental breakthroughs in the understanding of genetic and biological processes to develop new means of diagnosing and treating disease. Biotechnology is
It is proposed that developments in the commercialization of science and technology in "new economy" sectors such as telecommunications, information technology and biotechnology presage a new kind of